tiprankstipranks
Larimar Therapeutics presents Phase 1 and 2 dose studies of nomlabofusp
PremiumThe FlyLarimar Therapeutics presents Phase 1 and 2 dose studies of nomlabofusp
2M ago
Citi opens ‘positive catalyst watch’ on Larimar Therapeutics into data
Premium
The Fly
Citi opens ‘positive catalyst watch’ on Larimar Therapeutics into data
2M ago
Larimar Therapeutics Q3 2024 Financial Update
Premium
Company Announcements
Larimar Therapeutics Q3 2024 Financial Update
2M ago
Larimar Therapeutics initiated with an Outperform at Wedbush
PremiumThe FlyLarimar Therapeutics initiated with an Outperform at Wedbush
3M ago
Wedbush bullish on Larimar Therapeutics, initiates with an Outperform
Premium
The Fly
Wedbush bullish on Larimar Therapeutics, initiates with an Outperform
3M ago
Larimar Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Larimar Therapeutics initiated with a Buy at H.C. Wainwright
3M ago
Larimar Therapeutics plans PK run-in study in adolescents, children with FA
PremiumThe FlyLarimar Therapeutics plans PK run-in study in adolescents, children with FA
5M ago
Larimar Therapeutics reports Q2 EPS (34c), consensus (30c)
Premium
The Fly
Larimar Therapeutics reports Q2 EPS (34c), consensus (30c)
5M ago
LRMR Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
LRMR Upcoming Earnings Report: What to Expect?
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100